info.afrindex.com
China-Africa Trade Information Service
info.afrindex.com
China-Africa Trade Information Service
Image from Semonegna
Humanwell Healthcare (Group) Co., a Wuhan-based Chinese company will inaugurate its pharmaceutical factory, in the second week of December, built at a cost of 20 million USD at Amhara Regional State, learned The Ethiopian Herald.
Situated at 7ha. of land, the industrial plant is the first phase of the total 100 million USD investment by the Chinese healthcare solution provider.
The plant has been constructed in one and a half years and will, in short period of time, commence production. For the first phase , the Company targets to produce over 30 products in four dosage forms, tablets, capsules, injection and syrup. The Company will create jobs for over 300 people at its full capacity.
Group’s Integrated Manager Lu Xianjun says that Ethiopia has big market opportunities with growing population. The company would also export products to neighboring countries in near future.
Mekonnen Hailu, Communication Director at the Ethiopian Investment Commission (EIC) tells The Ethiopian Herald that Ethiopia has untapped potential for pharmaceutical sector as the country meets 85 percent of its demand from import. The opening of local manufacturing companies would help substitute import and save hard currency.
Local pharmaceutical companies have limited capacity and are few in number to meet domestic demand and the move by foreign companies such as Humanwell Healthcare (Group) Co. to set up factory is essential to meet the market demand and contribute significantly to the development of the sector. The pharmaceutical sector is at early stage and much needs to be done to attract foreign investors, says Mekonnen.
The factory will be inaugurated on the upcoming Sunday in the presence of senior officials and Chinese delegation. Headquartered at china, Humanwell Healthcare operates more than ten countries.
